720 related articles for article (PubMed ID: 32845742)
1. Recent advances in therapeutic modalities and vaccines to counter COVID-19/SARS-CoV-2.
Bilal M; Iqbal HMN
Hum Vaccin Immunother; 2020 Dec; 16(12):3034-3042. PubMed ID: 32845742
[TBL] [Abstract][Full Text] [Related]
2. New vaccine production platforms used in developing SARS-CoV-2 vaccine candidates.
Ura T; Yamashita A; Mizuki N; Okuda K; Shimada M
Vaccine; 2021 Jan; 39(2):197-201. PubMed ID: 33279318
[TBL] [Abstract][Full Text] [Related]
3. Human and novel coronavirus infections in children: a review.
Rajapakse N; Dixit D
Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
[TBL] [Abstract][Full Text] [Related]
4. The immunology of SARS-CoV-2 infection, the potential antibody based treatments and vaccination strategies.
Payandeh Z; Mohammadkhani N; Nabi Afjadi M; Khalili S; Rajabibazl M; Houjaghani Z; Dadkhah M
Expert Rev Anti Infect Ther; 2021 Jul; 19(7):899-910. PubMed ID: 33307883
[No Abstract] [Full Text] [Related]
5. Comparison of Immune Response between SARS, MERS, and COVID-19 Infection, Perspective on Vaccine Design and Development.
Ansariniya H; Seifati SM; Zaker E; Zare F
Biomed Res Int; 2021; 2021():8870425. PubMed ID: 33564683
[TBL] [Abstract][Full Text] [Related]
6. Challenges and prospects of COVID-19 vaccine development based on the progress made in SARS and MERS vaccine development.
Begum J; Mir NA; Dev K; Buyamayum B; Wani MY; Raza M
Transbound Emerg Dis; 2021 May; 68(3):1111-1124. PubMed ID: 32815655
[TBL] [Abstract][Full Text] [Related]
7. Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.
Lambert PH; Ambrosino DM; Andersen SR; Baric RS; Black SB; Chen RT; Dekker CL; Didierlaurent AM; Graham BS; Martin SD; Molrine DC; Perlman S; Picard-Fraser PA; Pollard AJ; Qin C; Subbarao K; Cramer JP
Vaccine; 2020 Jun; 38(31):4783-4791. PubMed ID: 32507409
[TBL] [Abstract][Full Text] [Related]
8. COVID-19 vaccines: The status and perspectives in delivery points of view.
Chung JY; Thone MN; Kwon YJ
Adv Drug Deliv Rev; 2021 Mar; 170():1-25. PubMed ID: 33359141
[TBL] [Abstract][Full Text] [Related]
9. Designing therapeutic strategies to combat severe acute respiratory syndrome coronavirus-2 disease: COVID-19.
Rohilla S
Drug Dev Res; 2021 Feb; 82(1):12-26. PubMed ID: 33216381
[TBL] [Abstract][Full Text] [Related]
10. The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies.
Frederiksen LSF; Zhang Y; Foged C; Thakur A
Front Immunol; 2020; 11():1817. PubMed ID: 32793245
[TBL] [Abstract][Full Text] [Related]
11. Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational development.
Kim E; Erdos G; Huang S; Kenniston TW; Balmert SC; Carey CD; Raj VS; Epperly MW; Klimstra WB; Haagmans BL; Korkmaz E; Falo LD; Gambotto A
EBioMedicine; 2020 May; 55():102743. PubMed ID: 32249203
[TBL] [Abstract][Full Text] [Related]
12. Risk management strategies and therapeutic modalities to tackle COVID-19/SARS-CoV-2.
Shah SMA; Rasheed T; Rizwan K; Bilal M; Iqbal HMN; Rasool N; Toma S; Marceanu LG; Bobescu E
J Infect Public Health; 2021 Mar; 14(3):331-346. PubMed ID: 33618278
[TBL] [Abstract][Full Text] [Related]
13. Potential Therapeutic Targets and Vaccine Development for SARS-CoV-2/COVID-19 Pandemic Management: A Review on the Recent Update.
Anand U; Jakhmola S; Indari O; Jha HC; Chen ZS; Tripathi V; Pérez de la Lastra JM
Front Immunol; 2021; 12():658519. PubMed ID: 34276652
[TBL] [Abstract][Full Text] [Related]
14. Drug Discovery Strategies for SARS-CoV-2.
Shyr ZA; Gorshkov K; Chen CZ; Zheng W
J Pharmacol Exp Ther; 2020 Oct; 375(1):127-138. PubMed ID: 32723801
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2/COVID-19 and advances in developing potential therapeutics and vaccines to counter this emerging pandemic.
Rabaan AA; Al-Ahmed SH; Sah R; Tiwari R; Yatoo MI; Patel SK; Pathak M; Malik YS; Dhama K; Singh KP; Bonilla-Aldana DK; Haque S; Martinez-Pulgarin DF; Rodriguez-Morales AJ; Leblebicioglu H
Ann Clin Microbiol Antimicrob; 2020 Sep; 19(1):40. PubMed ID: 32878641
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2: Structure, Biology, and Structure-Based Therapeutics Development.
Wang MY; Zhao R; Gao LJ; Gao XF; Wang DP; Cao JM
Front Cell Infect Microbiol; 2020; 10():587269. PubMed ID: 33324574
[TBL] [Abstract][Full Text] [Related]
17. An evidence-based systematic review on emerging therapeutic and preventive strategies to treat novel coronavirus (SARS-CoV-2) during an outbreak scenario.
Gudadappanavar AM; Benni J
J Basic Clin Physiol Pharmacol; 2020 Sep; 31(6):. PubMed ID: 32924964
[TBL] [Abstract][Full Text] [Related]
18. Vaccines for COVID-19: perspectives from nucleic acid vaccines to BCG as delivery vector system.
de Queiroz NMGP; Marinho FV; Chagas MA; Leite LCC; Homan EJ; de Magalhães MTQ; Oliveira SC
Microbes Infect; 2020; 22(10):515-524. PubMed ID: 32961274
[TBL] [Abstract][Full Text] [Related]
19. Neutralizing SARS-CoV-2.
Poeschla E
Elife; 2020 Dec; 9():. PubMed ID: 33320086
[TBL] [Abstract][Full Text] [Related]
20. COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics.
Dhama K; Sharun K; Tiwari R; Dadar M; Malik YS; Singh KP; Chaicumpa W
Hum Vaccin Immunother; 2020 Jun; 16(6):1232-1238. PubMed ID: 32186952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]